← FDA Drug Approvals (Drugs@FDA)
NAFTIFINE HYDROCHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: XIROMED · Approved 2020-09-22
Drug application
- FDA Application #
ANDA210038- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- NAFTIFINE HYDROCHLORIDE
- Generic name
- Naftifine Hydrochloride
- Active ingredients
- NAFTIFINE HYDROCHLORIDE
- Dosage form
- CREAM
- Route
- TOPICAL
- Marketing status
- Prescription
- Sponsor
- XIROMED
- First approval
- 2020-09-22
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown